News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Parker Albert P
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/09/2023 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns:
| Granted 18,864 shares
@ $0 Paid exercise price by delivering 5,463 shares
@ $0.5965, valued at
$3.3k
|
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/25/2023 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns:
| Granted 170,000 shares
@ $0 |
|
02/15/2022 |
4
| Parker Albert P (Chief Legal Officer) has filed a Form 4 on Zynerba Pharmaceuticals, Inc.
Txns:
| Granted 35,000 shares
@ $0 Granted 200,000 options to buy
@ $2.7, valued at
$540k
|
|
02/15/2022 |
3
| Parker Albert P (Chief Legal Officer) has filed a Form 3 on Zynerba Pharmaceuticals, Inc. |
12/15/2020 |
4
| Parker Albert P (COO) has filed a Form 4 on OncoCyte Corp
Txns:
| Granted 5,586 shares
@ $0 |
|
08/05/2020 |
4
| Parker Albert P (COO) has filed a Form 4 on OncoCyte Corp
Txns:
| Bought 5,000 shares
@ $1.3296, valued at
$6.6k
|
|
02/12/2020 |
4
| Parker Albert P (COO) has filed a Form 4 on Oncocyte Corp
Txns:
| Granted 204,000 options to buy
@ $2.63, valued at
$536.5k
|
|
03/18/2019 |
4
| Parker Albert P (COO) has filed a Form 4 on OncoCyte Corp
Txns:
| Granted 200,000 options to buy
@ $3.52, valued at
$704k
|
|
08/16/2018 |
3
| Parker Albert P (COO) has filed a Form 3 on OncoCyte Corp |
|
|